Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Management of Early Pregnancy Loss

Obstet Gynecol; ePub 2018 Nov; ACOG

The addition of a dose of mifepristone 24 hours before misoprostol administration in the medical management of early pregnancy loss may significantly improve treatment efficacy and should be considered when mifepristone is available. This according to an interim updated Practice Bulletin from the American College of Obstetricians and Gynecologists (ACOG) that reviews diagnostic approaches and describes options for the management of early pregnancy loss. The updated ACOG recommendations include:

  • In patients for whom medical management of early pregnancy loss is indicated, initial treatment using 800 micrograms of vaginal misoprostol is recommended, with a repeat dose as needed. The addition of a dose of mifepristone (200 mg orally) 24 hours before misoprostol administration in the medical management of early pregnancy loss may significantly improve treatment efficacy and should be considered when mifepristone is available. (Level A recommendation)
  • Although the risk of alloimmunization is low, the consequences can be significant, and administration of Rh D immune globulin should be considered in cases of early pregnancy loss, especially those that are later in the first trimester.
  • Because of the higher risk of alloimmunization, Rh D-negative women who have surgical management of early pregnancy loss should receive Rh D immune globulin prophylaxis.

Citation:

Early pregnancy loss. ACOG Practice Bulletin No. 200. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2018;132:e197–207.

This Week's Must Reads

Dental device borrowed from sports world no help in pushing, Bergh E et al. Am J Obstet Gynecol. 2019 Jan;220(1):S39, Abstract 49

One postdelivery antibiotic dose nearly halves infection in operative delivery, Knight M. et al. Am J Obstet Gynecol 2019 Jan;220;1:S685. Abstract LB 3.

Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al

Outcomes with Elective Induction of Labor at Term, Am J Obstet Gynecol; ePub 2019 Feb 1; Souter, et al

Must Reads in Clinical Guidelines

ACOG: Chronic Hypertension in Pregnancy, Obstet Gynecol; ePub 2019 Jan; Vidaeff, et al

ACOG Guidelines: Pregestational Diabetes Mellitus, Obstet Gynecol; ePub 2018 Dec; ACOG, et al

Management of Early Pregnancy Loss, Obstet Gynecol; ePub 2018 Nov; ACOG

Prophylactic Antibiotic Use in Labor & Delivery, Obstet Gynecol; 2018 Sep; Coleman, et al

USPSTF on Screening for Cervical Cancer, JAMA; 2018 Aug 21; US Preventive Services Task Force